Risperidone in the Treatment of PTSD in Women Survivors of Domestic Abuse and Rape Trauma

Completed · Phase 4

Conditions studied: Post-Traumatic Stress Disorder

In brief

This medical study is an assessment of clinical response in women with Posttraumatic Stress Disorder (PTSD) due to domestic violence or rape trauma when treated with risperidone. Response to risperidone or placebo (inactive drug) is measured by Clinician Administered PTSD Scale (CAPS) and Treatment Outcomes PTSD Scale (TOP-8). Second, the effect of risperidone on depressive and anxiety symptoms will be assessed using the Hamilton Rating Scale for Anxiety, Hamilton Rating Scale for Depression and the Clinical Global Impression.

Key facts

Study ID
NCT00208182
Run by
Creighton University
People needed
20
Starts
2001-07-01
Expected to finish
2004-08-01
Last updated by the study team
2006-03-10

Who can join

Age: 19 and older, up to 64. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.